GW PHARMA
GW Pharma focuses on the development and commercialization of innovative drugs for indications in the mental area (CNS), and hopes to provide faster, more effective and safer treatments for unmet needs in the clinical antidepressant field. drug. The team members have rich experience in CNS new drug research and development, and product pipelines are arranged around depression and anxiety. The current data of the company's core products proves that it has obvious safety advantages compared with the products already on the market.
GW PHARMA
Industry:
Health Care
Founded:
2016-01-01
Address:
Beijing, Beijing, China
Country:
China
Status:
Active
Total Funding:
0
Similar Organizations
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Investors List
Dynamic Balance Capital
Dynamic Balance Capital investment in Seed Round - GW Pharma
Tengye Ventures
Tengye Ventures investment in Seed Round - GW Pharma
More informations about "GW Pharma"
GW Pharmaceuticals - Crunchbase Company Profile
GW Pharmaceuticals closed its last funding round on Oct 2, 2018 from a Post-IPO Equity round. Who are GW Pharmaceuticals 's competitors? Alternatives and possible competitors to GW Pharmaceuticals may include Keros …See details»
GW Pharmaceuticals plc - AnnualReports.com
GW Pharmaceuticals is a cutting-edge UK-based biopharmaceutical company that over the last 20 years has established a world-leading position in cannabinoid science and the …See details»
CREATING AN INNOVATIVE, HIGH-GROWTH, GLOBAL …
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating …
DUBLIN and LONDON, Feb. 3, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered …See details»
Jazz to Acquire GW Pharmaceuticals
Feb 3, 2021 GW Pharmaceuticals’s directors and executive officers is set forth in GW Pharmaceuticals’ proxy statement on Schedule 14A for its 2020 Annual General Meeting, …See details»
GW Pharmaceuticals Company Profile 2024: Valuation, …
Zynerba Pharmaceuticals, Skye Bioscience, CNBX Pharmaceuticals, InMed Pharmaceuticals, and CohBar are some of the 7 competitors of GW Pharmaceuticals. When was GW Pharmaceuticals acquired? GW …See details»
Jazz Pharmaceuticals Completes Acquisition of GW …
May 6, 2021 The Company plans to provide 2021 financial guidance for the combined Jazz/GW organization within the next 45 days. Under the terms of the agreement, holders of GW ADSs, …See details»
Jazz Pharmaceuticals Completes Acquisition of GW …
May 5, 2021 Under the terms of the agreement, holders of GW ADSs, which each represented 12 GW ordinary shares, will be entitled to receive $220.00 for each GW ADS, consisting of …See details»
GW Pharmaceuticals : Jazz Pharmaceuticals Completes Acquisition …
DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader …See details»
Transforming Together: What Our Recent ... - Jazz Pharmaceuticals
With more than two decades spent pioneering cannabinoid science, GW Pharmaceuticals CEO Justin Gover and his team have built an impressive commercial portfolio and innovative …See details»
GW Pharmaceuticals - Overview, News & Similar companies
Jan 31, 2023 GW Pharmaceuticals contact info: Phone number: +44 1223266800 Website: www.gwpharm.co.uk What does GW Pharmaceuticals do? GW Pharmaceuticals' vision is to …See details»
Jazz Pharma to buy GW Pharma for $7.2 bln, adding cannabis …
Feb 3, 2021 Jazz Pharmaceuticals Plc (JAZZ.O) said on Wednesday it had agreed to buy GW Pharmaceuticals plc (GWPH.O) in a $7.2 billion cash-and-stock deal which will bolster its …See details»
Transforming Together: What Our Recent Acquisition Means for
May 5, 2021 With more than two decades spent pioneering cannabinoid science, GW Pharmaceuticals CEO Justin Gover and his team have built an impressive commercial …See details»
GW Pharmaceuticals - Products, Competitors, Financials, …
GW is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its cannabinoid product platform in a broad range of disease areas. Use the …See details»
GW Pharmaceuticals (GWPH) - Porton Down, United Kingdom
GW Pharmaceuticals was founded in 1998 and is listed on both the NASDAQ Global Market (GWPH) and AIM, a market of the London Stock Exchange. GW is licensed by the UK Home …See details»
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz
Apr 23, 2021 GW Pharmaceuticals Investor Contact: Scott Giacobello, Chief Financial Officer [email protected] +1 (760) 795 2200. Jazz Pharmaceuticals Media Contact: …See details»
GW Pharmaceuticals - Contacts, Employees, Board Members
GW Pharmaceuticals has 7 current employee profiles, including Chief Human Resources Officer Tina St Leger. GW Pharmaceuticals has 3 board members and advisors, including Geoffrey …See details»
GW Pharma - Products, Competitors, Financials, Employees, …
He is also on the board of EURAP-International Registry of Antiepileptic Drugs and Pregnancy, a non-profit organization which received financial support from Accord, Angelini, Bial, …See details»
GW Pharma - Crunchbase Company Profile & Funding
GW Pharma focuses on the development and commercialization of innovative drugs for indications in the mental area (CNS), and hopes to provide faster, more effective and safer …See details»
George Medicines signs exclusive licensing agreement with
1 hour ago London, UK, 13 January 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, has …See details»